Exceptional response to immunotherapy monotherapy in a patient with an unfavorable subset of cancer of unknown primary

被引：0
|
作者：
Huang, Xiangzhong [1 ]
Ren, Dongqing [1 ]
Sun, Qiulian [2 ]
Xu, Xinjian [1 ,3 ]
Ding, Yiwen [1 ,3 ]
机构：
[1] Nantong Univ, Jiangyin Hosp Affiliated, Dept Intervent Radiol, Jiangyin, Peoples R China
[2] Fifth Peoples Hosp Suzhou, Dept Radiol, Suzhou, Peoples R China
[3] Nantong Univ, Jiangyin Hosp Affiliated, Dept Intervent Radiol, 3 Yingrui Rd, Jiangyin 214400, Peoples R China
来源：
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY | 2023年 / 13卷 / 12期
关键词：
D O I：
10.21037/qims-23-284
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：8832 / 8838
页数：7
相关论文
共 50 条
  • [1] Case Report: Successful Immunotherapy Improved the Prognosis of the Unfavorable Subset of Cancer of Unknown Primary
    Mei, Jie
    Wang, Hao
    Fan, Honghong
    Ding, Junli
    Xu, Junying
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Clinical management of cancer of unknown primary with unfavorable subset: A retrospective analysis
    Tono, Yasutaka
    Sukeno, Koushi
    Tsunoda, Akira
    Oka, Hiroki
    Ishihara, Mikiya
    Saito, Kanako
    Tamaru, Satoshi
    Yamashita, Yoshiki
    Fujiwara, Takumi
    Kitajima, Takahito
    Okugawa, Yoshinaga
    Mizuno, Toshiro
    ANNALS OF ONCOLOGY, 2023, 34 : S1419 - S1419
  • [3] Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid Cancer
    Kollipara, Revathi
    Schneider, Bryan
    Radovich, Milan
    Babu, Sunil
    Kiel, Patrick J.
    ONCOLOGIST, 2017, 22 (10): : 1149 - 1151
  • [4] The prognostic impact of the putative primary site of breast and ovarian cancers in an unfavorable subset of cancer of unknown primary site
    Kodaira, M.
    Yonemori, K.
    Shimoi, T.
    Shimomura, A.
    Yunokawa, M.
    Shimizu, C.
    Fujiwara, Y.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary
    Posner, Atara
    Sivakumaran, Tharani
    Pattison, Andrew
    Etemadmoghadam, Dariush
    Thio, Niko
    Wood, Colin
    Fisher, Krista
    Webb, Samantha
    DeFazio, Anna
    Wilcken, Nicholas
    Gao, Bo
    Karapetis, Christos S.
    Singh, Madhu
    Collins, Ian M.
    Richardson, Gary
    Steer, Christopher
    Warren, Mark
    Karanth, Narayan
    Fellowes, Andrew
    Fox, Stephen B.
    Hicks, Rodney J.
    Schofield, Penelope
    Bowtell, David
    Prall, Owen W. J.
    Tothill, Richard William
    Mileshkin, Linda
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (01)
  • [6] Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site
    Makoto Kodaira
    Kan Yonemori
    Tatsunori Shimoi
    Akihiko Yoshida
    Masayuki Yoshida
    Atsuko Kitano
    Akihiko Shimomura
    Mayu Yunokawa
    Chikako Shimizu
    Yuichi Takiguchi
    Yasuhiro Fujiwara
    Kenji Tamura
    BMC Cancer, 18
  • [7] Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site
    Kodaira, Makoto
    Yonemori, Kan
    Shimoi, Tatsunori
    Yoshida, Akihiko
    Yoshida, Masayuki
    Kitano, Atsuko
    Shimomura, Akihiko
    Yunokawa, Mayu
    Shimizu, Chikako
    Takiguchi, Yuichi
    Fujiwara, Yasuhiro
    Tamura, Kenji
    BMC CANCER, 2018, 18
  • [8] Exceptional response to immunotherapy in a patient with hepatocellular carcinoma
    McCord, M. L.
    Garcia, A.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 367 : S178 - S179
  • [9] Brachytherapy monotherapy may be sufficient for a subset of patients with unfavorable intermediate risk prostate cancer
    King, Martin T.
    Chen, Ming-Hui
    Moran, Brian J.
    Braccioforte, Michelle H.
    Buzurovic, Ivan
    Muralidhar, Vinayak
    Yang, David D.
    Mouw, Kent W.
    Devlin, Phillip M.
    D'Amico, Anthony V.
    Nguyen, Paul L.
    Orio, Peter F., III
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (04) : 157.e15 - 157.e20
  • [10] Wilms tumor gene (WT-1) expression in female patients with unfavorable subset of cancer of unknown primary site
    Kodaira, M.
    Yonemori, K.
    Shimoi, T.
    Shimomura, A.
    Yunokawa, M.
    Shimizu, C.
    Fujiwara, Y.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2016, 27
12345